Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP
TC BioPharm is an innovative biotechnology research company focused on pioneering advancements in cell therapy. With a commitment to combating cancer and infectious diseases, TC BioPharm is dedicated to developing cutting-edge allogeneic CAR-T cell therapy products and gamma delta T cell therapies.
Located at Maxim 1, 2 Parklands Way, Eurocentral, Holytown, North Lanarkshire ML1 4WR, GB, TC BioPharm operates with a growing team of experts and scientific advisors. The company's Glasgow office serves as a hub for research and development, fostering collaboration with partner organizations to drive innovation in regenerative medicine and stratified medicine.
TC BioPharm is publicly traded and committed to advancing clinical-grade cell therapy and cancer immunotherapy. The company aims to revolutionize the treatment landscape and improve patient outcomes. We invite the manager of TC BioPharm to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and commercial development.
Other organizations in the same industry
This company is also known as